Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Deaths: leading causes for 2016.Natl Vital Stat Rep. 2018; 67: 1-77
- Assessment of the worldwide burden of critical illness: the Intensive Care over Nations (ICON) audit.Lancet Respir Med. 2014; 2: 380-386
- The third international consensus definitions for sepsis and septic shock (Sepsis-3).JAMA. 2016; 315: 801-810
- The global burden of sepsis: barriers and potential solutions.Crit Care. 2018; 22: 232
- Recognizing sepsis as a global health priority – A WHO Resolution.N Engl J Med. 2017; 377: 414-417
- Host biomarkers distinguishing bacterial from non-bacterial causes of acute febrile illness: a comprehensive review.PLoS One. 2016; 11: e0160278
- SIRS in the time of sepsis-3.Chest. 2018; 153: 34-38
- The early identification of disease progression in patients with suspected infection presenting to the emergency department: a multicentre derivation and validation study.Crit Care. 2019; 23: 40
- Pathogen recognition by the innate immune system.Int Rev Immunol. 2011; 30: 16-34
- Host innate immune response to sepsis.Virulence. 2014; 5: 36-44
- TLRs/NLRs: shaping the landscape of host immunity.Int Rev Immunol. 2018; 37: 3-19
- Biomarkers of sepsis.Crit Rev Clin Lab Sci. 2013; 50: 23-36
- American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.Crit Care Med. 1992; 20: 864-874
- Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock.Crit Care Med. 2008; 36: 296-327
- Guidelines to manage community-acquired pneumonia.Clin Chest Med. 2018; 39: 723-731
- The role of biomarkers in the diagnosis and management of pneumonia.Clin Chest Med. 2018; 39: 691-701
- Sequential organ failure assessment score is an excellent operationalization of disease severity of adult patients with hospitalized community-acquired pneumonia – results from the prospective observational PROGRESS study.Crit Care. 2019; 23: 110
- Predicting ICU admission in community-acquired pneumonia: clinical scores and biomarkers.Expert Rev Clin Pharmacol. 2012; 5: 445-458
- Utility of procalcitonin, C-reactive protein, and white blood cells alone and in combination for the prediction of clinical outcomes in community-acquired pneumonia.Clin Chem Lab Med. 2015; 53: 559-566
- Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3).JAMA. 2016; 315: 762-774
- Laboratory diagnosis of bacteremia and fungemia.Infect Dis Clin North Am. 2001; 15: 1009-1024
- Blood cultures: key elements for best practices and future directions.J Infect Chemother. 2010; 16: 301-306
- The epidemiology of sepsis in the United States from 1979 through 2000.N Engl J Med. 2003; 348: 1546-1554
- Antimicrobial therapy for patients with severe sepsis and septic shock: an evidence based review.Crit Care Med. 2004; 32: S495-S512
- Characteristics and outcomes of culture-negative versus culture-positive severe sepsis.Crit Care. 2013; 17: R202
- Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.Clin Pharmacol Ther. 2001; 69: 89-95
- Biomarkers of sepsis.Crit Care Med. 2009; 37: 2290-2298
- Sepsis biomarker: a review.Crit Care. 2010; 14: R15
- Clinical Trials. List of open studies regarding “sepsis AND biomarkers” 2017.(Available at:) (Accessed April 9, 2019)
- Clinical Trials. List of open studies regarding “pneumonia AND biomarkers” 2017.(Available at:) (Accessed April 9, 2019)
- Real-world use of procalcitonin and other biomarkers among sepsis hospitalizations in the United States: a retrospective, observational study.PLoS One. 2018; 13: e0205924
- Acute-phase proteins and other systemic responses to inflammation.N Engl J Med. 1999; 340: 448-454
- C-reactive protein.J Biol Chem. 2004; 279: 48487-48490
- Interpretation of C-reactive protein concentrations in critically ill patients.Biomed Res Int. 2013; 2013: 124021
- Biomarkers in the critically ill patient: C-reactive protein.Crit Care Clin. 2011; 27: 241-251
- Procalcitonin versus C-reactive protein: review of kinetics and performance for diagnosis of neonatal sepsis.J Perinatol. 2019; https://doi.org/10.1038/s41372-019-0363-4
- Laboratory detection of sepsis: biomarkers and molecular approaches.Clin Lab Med. 2013; 33: 413-437
- Biomarker-guided antibiotic therapy – strengths and limitations.Ann Transl Med. 2017; 5: 208
- Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3.J Clin Immunol. 2008; 28: 1-13
- Source of circulating pentraxin 3 in septic shock patients.Front Immunol. 2019; 9: 3048
- Pentraxins in humoral immunity.Adv Exp Med Biol. 2012; 946: 1-20
- Persisting high levels of pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality.Intensive Care Med. 2010; 36: 621-629
- Diagnostic value of pentraxin-3 in patients with sepsis and septic shock in accordance with latest sepsis-3 definitions.BMC Infect Dis. 2017; 17: 554
- PTX3 predicts severe disease in febrile patients in the emergency department.J Infect. 2010; 60: 122-127
- Pentraxin 3 (PTX3) is associated with severe sepsis and fatal disease in emergency room patients with suspected infection: a prospective cohort study.PLoS One. 2013; 8: e53661
- Procalcitonin and the role of biomarkers in the diagnosis and management of sepsis.Diagn Microbiol Infect Dis. 2012; 73: 221-227
- High serum procalcitonin concentrations in patients with sepsis and infection.Lancet. 1993; 341: 515-518
- Pathobiochemistry and clinical use of procalcitonin.Clin Chim Acta. 2002; 323: 17-29
- Ubiquitous expression of the calcitonin-I gene in multiple tissues in response to sepsis.J Clin Endocrinol Metab. 2001; 86: 396-404
- Kinetics of procalcitonin in iatrogenic sepsis.Intensive Care Med. 1998; 24: 888-889
- Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors.J Clin Endocrinol Metab. 2004; 89: 1512-1525
- High circulating levels of the IL-1 type II decoy receptor in critically ill patients with sepsis: association of decoy receptor levels with glucocorticoid administration.J Leukoc Biol. 2002; 72: 643-649
- Procalcitonin levels predict bacteremia in patients with community-acquired pneumonia: a prospective clinical trial.Chest. 2010; 138: 121-129
- Additional value of procalcitonin for diagnosis of infection in patients with fever in the emergency department.Crit Care Med. 2010; 38: 457-463
- Procalcitonin as a marker for the detection of bacteremia and sepsis in the emergency department.Am J Clin Pathol. 2011; 135: 182-189
- Diagnostic utilities of procalcitonin and C-reactive protein for the prediction of bacteremia determined by blood culture.Clin Chim Acta. 2012; 413: 1731-1736
- Procalcitonin and C-reactive protein in early diagnosis of sepsis caused by either Gram-negative or Gram-positive bacteria.Ir J Med Sci. 2017; 186: 207-212
- Influence of pathogen and focus of infection on procalcitonin levels in sepsis patients with bacteremia or candidemia.Crit Care. 2018; 22: 128
- Serum procalcitonin for discrimination of blood contamination from bloodstream infection due to coagulase-negative staphylococci.Infection. 2007; 35: 352-355
- Diagnostic value of procalcitonin for bacterial infection in elderly patients in the emergency department.J Am Geriatr Soc. 2010; 58: 518-522
- Comparison between procalcitonin and C-reactive protein for early diagnosis of children with sepsis and septic shock.Inflamm Res. 2010; 59: 581-586
- Procalcitonin test in the diagnosis of bacteremia: a meta-analysis.Ann Emerg Med. 2007; 50: 34-41
- Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis.Clin Infect Dis. 2004; 39: 206-217
- Procalcitonin as a diagnostic test for sepsis in critically ill adults after surgery or trauma: a systematic review and meta-analysis.Crit Care Med. 2006; 34: 1996-2003
- Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis.Intensive Care Med. 2011; 37: 747-762
- Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis.Lancet Infect Dis. 2013; 14: 426-435
- Accuracy of serum procalcitonin for the diagnosis of sepsis in neonates and children with systemic inflammatory syndrome: a meta-analysis.BMC Infect Dis. 2017; 17: 302
- Diagnostic and prognostic biomarkers of sepsis in critical care.J Antimicrob Chemother. 2011; 66: 33-40
- Diagnostic efficacy and prognostic value of serum procalcitonin concentration in patients with suspected sepsis.J Intensive Care Med. 2009; 24: 63-71
- Use of procalcitonin to shorten antibiotic treatment duration in septic patients.Am J Respir Crit Care Med. 2008; 177: 498-505
- Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.Lancet. 2010; 375: 463-474
- Procalcitonin to guide duration of antimicrobial therapy in intensive care units: a systematic review.Clin Infect Dis. 2011; 53: 379-387
- Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendation for clinical algorithms.Arch Intern Med. 2011; 171: 1322-1331
- Serial procalcitonin predicts mortality in severe sepsis patients: results from the Multicenter Procalcitonin Monitoring Sepsis (MOSES) study.Crit Care Med. 2017; 45: 781-789
- Effect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients: a patient-level meta-analysis of randomized trials.Crit Care. 2018; 22: 191
- Practice patterns and outcomes associated with procalcitonin use in critically ill patients with sepsis.Clin Infect Dis. 2017; 64: 1509-1515
- Adrenomedullin, a multifunctional regulatory peptide.Endocr Rev. 2000; 21: 138-167
- Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis.J Clin Endocrinol Metab. 1996; 81: 1449-1453
- Mid-regional proadrenomedullin as a prognostic marker in sepsis: an observational study.Crit Care. 2005; 9: R816-R824
- Assessment of pro-vasopressin and pro-adrenomedullin as predictors of 28-day mortality in septic shock patients.Intensive Care Med. 2009; 35: 1859-1867
- The utility of proadrenomedullin and procalcitonin in comparison to C-reactive protein as predictors of sepsis and bloodstream infection in critically ill patients with cancer.Crit Care Med. 2014; 42: 2500-2507
- The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis – a secondary analysis of a larger randomised controlled trial.Crit Care. 2018; 22: 79
- Mid regional pro-adrenomedullin for the prediction of organ failure in infection. Results from a single centre study.PLoS One. 2018; 13: e0201491
- Superior accuracy of mid-regional proadrenomedullin for mortality prediction in sepsis with varying levels of illness severity.Ann Intensive Care. 2017; 7: 15
- Assessment of adrenomedullin and proadrenomedullin as predictors of mortality in septic patients: a systematic review and meta-analysis.Med Intensiva. 2018; 42: 416-424
- Serum lactate as a predictor of mortality in patients with infection.Intensive Care Med. 2007; 33: 970-977
- Whole blood lactate kinetics in patients undergoing quantitative resuscitation for severe sepsis and septic shock.Chest. 2013; 143: 1548-1553
- Diagnostic characteristics of a clinical screening tool in combination with measuring bedside lactate level in emergency department patients with suspected sepsis.Acad Emerg Med. 2014; 21: 853-857
- Etiology and therapeutic approach to elevated lactate.Mayo Clin Proc. 2013; 88: 1127-1140
- Prevalence and characteristics of nonlactate and lactate expressors in septic shock.J Crit Care. 2012; 27: 344-350
- Interleukin-1 receptor antagonist and interleukin-6 for early diagnosis of neonatal sepsis 2 days before clinical manifestations.Lancet. 1998; 352: 1271-1277
- Early detection of severe sepsis in the emergency room: diagnostic value of C-reactive protein, procalcitonin, and interleukin-6.Scand J Infect Dis. 2011; 43: 883-890
- A combined score of pro- and antiinflammatory interleukins improves mortality prediction in severe sepsis.Cytokine. 2012; 57: 332-336
- Biomarkers for diagnosis of neonatal infections: a systematic analysis of their potential as a point-of-care diagnostics.J Glob Health. 2011; 1: 201-209
- TREM-1 amplifies inflammation and is a crucial mediator of sepsis.Nature. 2001; 410: 1103-1107
- Accuracy of plasma sTREM-1 for sepsis diagnosis in systemic inflammatory patients: a systematic review and meta-analysis.Crit Care. 2012; 16: R229
- Soluble triggering receptor expressed on myeloid cell-1 (sTREM-1): a potential biomarker for the diagnosis of infectious diseases.Front Med. 2017; 11: 169-177
- Usefulness of presepsin sCD14-ST measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria for systemic inflammatory response syndrome.J Infect Chemother. 2011; 17: 764-769
- Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study.J Infect Chemother. 2012; 18: 891-897
- Biomarkers of sepsis.Biomed Res Int. 2014; 2014: 547818
- Biomarkers in the management of pneumonia.Expert Rev Respir Med. 2008; 2: 565-572
- Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia.BMC Infect Dis. 2007; 7: 10
- Procalcitonin in children admitted to hospital with community acquired pneumonia.Arch Dis Child. 2001; 84: 332-336
- Procalcitonin levels in community-acquired pneumonia – correlation with aetiology and severity.Scand J Infect Dis. 2014; 46: 787-791
- Prognostic value of proadrenomedullin in severe sepsis and septic shock with community-acquired pneumonia.Swiss Med Wkly. 2012; 142: w13542
- Midregional proadrenomedullin for prognosis in community-acquired pneumonia: a systematic review.Respir Med. 2014; 108: 1569-1580
- Effect of procalcitonin-based guidelines vs. standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.JAMA. 2009; 302: 1059-1066
- Procalcitonin to guide antibiotic decision making.Curr Opin Infect Dis. 2019; 32: 130-135
- Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient-level meta-analysis.Lancet Infect Dis. 2018; 19: 95-107
- Procalcitonin-guided use of antibiotics for lower respiratory tract infection.N Engl J Med. 2018; 379: 236-249
- Systematic review and meta-analysis of procalcitonin-guidance versus usual care for antimicrobial management in critically ill patients: focus on subgroups based on antibiotic initiation, cessation, or mixed strategies.Crit Care Med. 2018; 46: 684-690
- The role of procalcitonin in the diagnosis of meningitis: a literature review.J Clin Med. 2018; 7: 148
- Diagnostic accuracy of cerebrospinal fluid procalcitonin in bacterial meningitis patients with empiric antibiotic pretreatment.J Clin Microbiol. 2017; 55: 1193-1204
- Procalcitonin and pyuria-based algorithm reduces antibiotic use in urinary tract infections: a randomized controlled trial.BMC Med. 2015; 13: 104
- The emerging field of quantitative blood metabolomics for biomarker discovery in critical illnesses.Am J Respir Crit Care. 2011; 184: 647-655
- Enhanced understanding of the host-pathogen interaction in sepsis: new opportunities for omic approaches.Lancet Respir Med. 2017; 5: 212-223
- Robust classification of bacterial and viral infections via integrated host gene expression diagnostics.Sci Transl Med. 2016; 8: 346ra91
- Shifting the paradigm from pathogen to pathobiome: new concepts in the light of meta-omics.Front Cell Infect Microbiol. 2014; 4: 29
Article info
Footnotes
Disclosure: S. Riedel has received research funding in the past from B.R.A.H.M.S. AG, Henningsdorf, Germany and Thermo Fisher Scientific, Middletown, VA.
Identification
Copyright
© 2019 Elsevier Inc. All rights reserved.
